## Core Concept
Refsum's disease is a rare genetic disorder characterized by the accumulation of a specific type of fatty acid, phytanic acid, due to a defect in its breakdown. This condition leads to various neurological and systemic symptoms. The genetic defect affects the enzyme responsible for the initial step in phytanic acid alpha-oxidation.

## Why the Correct Answer is Right
The correct answer, **phytanoyl-CoA hydroxylase** or more accurately related to the provided options, the defect in Refsum's disease is associated with the gene **PHYH** (phytanoyl-CoA hydroxylase) or **PEX7** (peroxisomal biogenesis factor 7), which is crucial for the proper functioning of peroxisomes where phytanic acid is broken down. The PHYH gene provides instructions for making an enzyme called phytanoyl-CoA hydroxylase, which is involved in the breakdown of phytanic acid. A defect in this enzyme leads to Refsum's disease.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not accurately represent the genetic defect associated with Refsum's disease.
- **Option B:** This is incorrect as it does not specifically relate to the enzyme deficiency seen in Refsum's disease.
- **Option C:** This option might relate to other genetic conditions but is not directly linked to the primary defect in Refsum's disease.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that Refsum's disease is one of the peroxisomal biogenesis disorders (when considering the role of PEX7) or a single enzyme deficiency disorder (PHYH), highlighting the importance of peroxisomal function in fatty acid metabolism. Clinicians should consider dietary restriction of phytanic acid as a management strategy.

## Correct Answer Line
**Correct Answer: B. phytanoyl-CoA hydroxylase.**